Study of Skin Parameters in the PROOF Cohort
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Skin Aging
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Enrollment
- 209
- Locations
- 1
- Primary Endpoint
- SCINEXA score
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
This study aims to evaluate skin aging of an homogeneous population of 77 years old patient selected among the PROOF cohort who has been continuously investigated by cardiological examination.
Skin aging will be explored by macroscopic and microscopic evaluation. In particular, skin aging will be measured by an index of clinical aging (SCINEXA) and other complementary measures such as facial photos, standard and High Definition dermoscopy, elastography, sebumetry, in vivo and ex vivo confocal microscopy, and classical histological examinations.
Investigators
Eligibility Criteria
Inclusion Criteria
- •included in the PROOF cohort
- •Form consent signed
Exclusion Criteria
- •Past history of surgery and / or treatment of aesthetic medicine
- •neurological disorders
- •insulin-dependent diabetes,
- •corticosteroids or retinoids (isotretinoin, ...) \> 1 year
Outcomes
Primary Outcomes
SCINEXA score
Time Frame: Day 1
The aging of the skin is evaluated by a semi-quantitative composite of 19 clinical variables : the score SCINEXA
Secondary Outcomes
- ex vivo confocal microscopy(Day 1)
- histology(Day 1)
- in vivo confocal microscopy(Day 1)
- RAMAN(Day 1)